GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
OSL:GENT - Euronext Oslo - NO0010748866 - Common Stock - Currency: NOK
GENT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 57 industry peers in the Health Care Equipment & Supplies industry. GENT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. GENT is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
GENT had positive earnings in the past year.
In the past year GENT had a positive cash flow from operations.
In the past 5 years GENT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
GENT's Return On Assets of 20.72% is amongst the best of the industry. GENT outperforms 96.49% of its industry peers.
GENT has a Return On Equity of 24.02%. This is amongst the best in the industry. GENT outperforms 91.23% of its industry peers.
The Return On Invested Capital of GENT (9.20%) is better than 77.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.72% | ||
| ROE | 24.02% | ||
| ROIC | 9.2% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GENT has a Profit Margin of 30.93%. This is amongst the best in the industry. GENT outperforms 96.49% of its industry peers.
The Operating Margin of GENT (15.72%) is better than 75.44% of its industry peers.
GENT has a Gross Margin (57.48%) which is in line with its industry peers.
In the last couple of years the Gross Margin of GENT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.72% | ||
| PM (TTM) | 30.93% | ||
| GM | 57.48% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GENT is still creating some value.
GENT has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, GENT has about the same amount of shares outstanding.
GENT has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 17.73 indicates that GENT is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 17.73, GENT belongs to the best of the industry, outperforming 98.25% of the companies in the same industry.
GENT has a debt to FCF ratio of 0.56. This is a very positive value and a sign of high solvency as it would only need 0.56 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.56, GENT belongs to the best of the industry, outperforming 96.49% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that GENT is not too dependend on debt financing.
GENT's Debt to Equity ratio of 0.02 is amongst the best of the industry. GENT outperforms 94.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.56 | ||
| Altman-Z | 17.73 |
ROIC/WACC1.07
WACC8.59%
2.3 Liquidity
A Current Ratio of 6.08 indicates that GENT has no problem at all paying its short term obligations.
GENT's Current ratio of 6.08 is amongst the best of the industry. GENT outperforms 98.25% of its industry peers.
GENT has a Quick Ratio of 4.21. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.21, GENT belongs to the best of the industry, outperforming 96.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.08 | ||
| Quick Ratio | 4.21 |
3. Growth
3.1 Past
GENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 931.98%, which is quite impressive.
Looking at the last year, GENT shows a quite strong growth in Revenue. The Revenue has grown by 11.14% in the last year.
Measured over the past years, GENT shows a very strong growth in Revenue. The Revenue has been growing by 25.96% on average per year.
EPS 1Y (TTM)931.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.46%
Revenue 1Y (TTM)11.14%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%15.58%
3.2 Future
The Earnings Per Share is expected to grow by 58.89% on average over the next years. This is a very strong growth
Based on estimates for the next years, GENT will show a very strong growth in Revenue. The Revenue will grow by 31.72% on average per year.
EPS Next Y76.24%
EPS Next 2Y58.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 18.78, the valuation of GENT can be described as rather expensive.
84.21% of the companies in the same industry are more expensive than GENT, based on the Price/Earnings ratio.
GENT is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
GENT is valuated rather expensively with a Price/Forward Earnings ratio of 22.45.
Based on the Price/Forward Earnings ratio, GENT is valued a bit cheaper than 63.16% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of GENT to the average of the S&P500 Index (21.76), we can say GENT is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.78 | ||
| Fwd PE | 22.45 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as GENT.
GENT's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 116.71 | ||
| EV/EBITDA | 24.11 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GENT's earnings are expected to grow with 58.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y58.89%
EPS Next 3YN/A
5. Dividend
5.1 Amount
GENT has a yearly dividend return of 0.64%, which is pretty low.
Compared to an average industry Dividend Yield of 2.07, GENT pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.37, GENT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.64% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y58.89%
EPS Next 3YN/A
OSL:GENT (7/11/2025, 7:00:00 PM)
58.4
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners26.83%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap900.53M
Analysts85.71
Price Target68.34 (17.02%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.64% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.78 | ||
| Fwd PE | 22.45 | ||
| P/S | 5.7 | ||
| P/FCF | 116.71 | ||
| P/OCF | 51.5 | ||
| P/B | 4.43 | ||
| P/tB | 5.19 | ||
| EV/EBITDA | 24.11 |
EPS(TTM)3.11
EY5.33%
EPS(NY)2.6
Fwd EY4.45%
FCF(TTM)0.5
FCFY0.86%
OCF(TTM)1.13
OCFY1.94%
SpS10.25
BVpS13.2
TBVpS11.26
PEG (NY)0.25
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.72% | ||
| ROE | 24.02% | ||
| ROCE | 11.95% | ||
| ROIC | 9.2% | ||
| ROICexc | 16.06% | ||
| ROICexgc | 21.45% | ||
| OM | 15.72% | ||
| PM (TTM) | 30.93% | ||
| GM | 57.48% | ||
| FCFM | 4.88% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score6
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.56 | ||
| Debt/EBITDA | 0.13 | ||
| Cap/Depr | 108.56% | ||
| Cap/Sales | 6.18% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 51.66% | ||
| Profit Quality | 15.78% | ||
| Current Ratio | 6.08 | ||
| Quick Ratio | 4.21 | ||
| Altman-Z | 17.73 |
F-Score6
WACC8.59%
ROIC/WACC1.07
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)931.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.46%
EPS Next Y76.24%
EPS Next 2Y58.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.14%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%15.58%
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1545.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y139.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y399.35%
OCF growth 3YN/A
OCF growth 5YN/A